Blog
Zai Lab Q1 Earnings Call Highlights
Zai Lab (NASDAQ:ZLAB) reported a year-over-year decline in first-quarter 2026 product revenue as pressure on ZEJULA weighed on results, while management
Zymeworks Q1 Earnings Call Highlights
Zymeworks (NASDAQ:ZYME) reported a wider first-quarter loss as revenue declined from year-earlier milestone payments, while management
Xometry Q1 Earnings Call Highlights
Xometry (NASDAQ:XMTR) reported accelerating first-quarter 2026 growth and raised its full-year outlook, citing stronger marketplace
Xeris Biopharma Q1 Earnings Call Highlights
Xeris Biopharma (NASDAQ:XERS) reported a sharp increase in first-quarter 2026 revenue and raised the low end of its full-year revenue outlook, citing strong demand for RECORLEV and continued
Xenon Pharmaceuticals Q1 Earnings Call Highlights
Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to submit a new drug application to the U.S. Food and Drug Administration
T. Rowe Price Group Shareholders Back Board as ETF Assets Top $25 Billion
T. Rowe Price Group (NASDAQ:TROW) held its 2026 annual meeting of stockholders virtually, with Chair, CEO and President Robert Sharps
TeraWulf Q1 Earnings Call Highlights
TeraWulf (NASDAQ:WULF) said its first-quarter 2026 results reflected a business shifting from Bitcoin mining toward contracted high-performance
Wynn Resorts Q1 Earnings Call Highlights
Wynn Resorts (NASDAQ:WYNN) executives said the casino operator delivered strong first-quarter results across Las Vegas and Macau while
WW International Q1 Earnings Call Highlights
WW International (NASDAQ:WW), operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results
WillScot Q1 Earnings Call Highlights
WillScot (NASDAQ:WSC) reported first-quarter 2026 results that management said exceeded its expectations, as stronger large-project activity and
Warner Music Group Q2 Earnings Call Highlights
Warner Music Group (NASDAQ:WMG) reported stronger fiscal second-quarter results, with executives saying the company’s growth strategy is
Willdan Group Q1 Earnings Call Highlights
Willdan Group (NASDAQ:WLDN) reported a stronger-than-expected start to fiscal 2026, with executives citing margin expansion, improved
Thomson Reuters Defends AI Moat as Compliance Complexity Fuels Growth
Thomson Reuters (NASDAQ:TRI) executives said the company is positioned to benefit from rising compliance complexity and demand for specialized artificial
WhiteHorse Finance Q1 Earnings Call Highlights
WhiteHorse Finance (NASDAQ:WHF) reported lower first-quarter earnings and a decline in net asset value as previously identified credit issues weighed on results, while management said share
Wendy's Q1 Earnings Call Highlights
Wendy's (NASDAQ:WEN) reported first-quarter results that management said were largely in line with expectations, while acknowledging the restaurant
Westrock Coffee Q1 Earnings Call Highlights
Westrock Coffee (NASDAQ:WEST) reported sharply higher first-quarter 2026 results, with management saying the company has moved beyond a multiyear investment
Varex Imaging Q2 Earnings Call Highlights
Varex Imaging (NASDAQ:VREX) reported fiscal second-quarter revenue within its guidance range and said demand remained solid across its medical and industrial businesses, while management
Vital Farms Q1 Earnings Call Highlights
Vital Farms (NASDAQ:VITL) executives said the company’s first-quarter results and early second-quarter scanner data fell short of
Verastem Q1 Earnings Call Highlights
Verastem (NASDAQ:VSTM) reported first-quarter 2026 net product revenue of $18.7 million for AVMAPKI FAKZYNJA CO-PACK, as management said the launch of the therapy for KRAS-mutated recurrent
Vertex Q1 Earnings Call Highlights
Vertex (NASDAQ:VERX) reported first-quarter 2026 results above its guidance range and raised its full-year profitability outlook as
Victory Capital Q1 Earnings Call Highlights
Victory Capital (NASDAQ:VCTR) reported record first-quarter 2026 results, with executives pointing to higher gross flows, the contribution from the Pioneer acquisition and continued growth in its
Vericel Q1 Earnings Call Highlights
Vericel (NASDAQ:VCEL) reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage
Upwork Q1 Earnings Call Highlights
Upwork (NASDAQ:UPWK) said first-quarter 2026 results reflected a sharp shift in demand late in the period, as macroeconomic uncertainty and faster adoption
Entrada Therapeutics DMD Trial Shows Early Functional Gains, Clean Safety Profile
Entrada Therapeutics (NASDAQ:TRDA) said initial data from the first cohort of its phase I/II ELEVATE-44-201 trial showed favorable
10x Genomics Q1 Earnings Call Highlights
10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to

